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Abstract
Background: Control of Allergic Rhinitis and Asthma Test for Children (CA-
RATKids) is the first questionnaire that assesses simultaneously allergic rhinitis and
asthma control in children. It was recently developed, but redundancy of questions
and its psychometric properties were not assessed. This study aimed to (i) establish the
final version of the CARATKids questionnaire and (ii) evaluate its reliability,
responsiveness, cross-sectional validity, and longitudinal validity.
Methods: A prospective observational study was conducted in 11 Portuguese centers.
During two visits separated by 6 wk, CARATKids, visual analog scale scales and
childhood asthma control test were completed, and participant’s asthma and rhinitis
were evaluated by his/her physician without knowing the questionnaires’ results. Data-
driven item reduction was conducted, and internal consistency, responsiveness
analysis, and associations with external measures of disease status were assessed.
Results: Of the 113 children included, 101 completed both visits. After item reduction,
the final version of the questionnaire has 13 items, eight to be answered by the child
and five by the caregiver. Its Cronbach’s alpha was 0.80, the Guyatt’s responsiveness
index was 1.51, and a significant (p < 0.001) within-patient change of CARATKids
score in clinical unstable patients was observed. Regarding cross-sectional validity,
correlation coefficients of CARATKids with the external measures of control were
between 0.45 and 0.69 and met the a priori predictions. In the longitudinal validity
assessment, the correlation coefficients between the score changes of CARATKids and
those of external measures of control ranged from 0.34 to 0.46.
Conclusion: CARATKids showed adequate psychometric properties and is ready to be
used in clinical practice.
Asthma and allergic rhinitis (ARA) are chronic inflammatory
diseases of the airways that often coexist in children (1).
Rhinitis increases the risk of asthma and impairs its control
(2–4). When non-controlled, these conditions are responsible
for a significant decrease in patient’s quality of life (1).
Currently, clinical asthma control is defined as the frequency
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and intensity of symptoms and functional limitations that a
patient experiences or has recently experienced as a conse-
quence of the disease and includes day and night symptoms,
use of reliever therapy, activity limitations, and lung function
measurements (5). Rhinitis control has never been formally
defined. Nevertheless, Demoly et al. (6) recently argued for the
use of the concept of rhinitis control as a way to improve
clinical decisions.
CARAT10 was the first tool that was developed and
validated to assess ARA control in adults (age ≥ 18 yr)
(6–8). In children, until recently, there were several available
tools evaluating asthma control, but as far as we know, there
was no tool assessing the control of rhinitis or ARA. Control
of Allergic Rhinitis and Asthma Test for Children (CARATK-
ids) was developed to evaluate ARA control in children with
6–12 yr old. This initial version of CARATKids has 17-item
and was developed from CARAT and other pediatric ques-
tionnaires, in a two-phase study with consensus meetings
between specialized physicians on the area, and cognitive
interviews of children and their caregivers (7); it uses a
dichotomic scale (Yes/No answers), with easily understandable
questions and images for children.
This study aims to (i) define the final version of the
CARATKids questionnaire (item reduction and content struc-
ture and layout improvement) and (ii) to evaluate its reliability,
responsiveness, and cross-sectional and longitudinal validity.
Methods
Study design and setting
A multicentric prospective observational study was conducted
in eleven centers located in five of the seven Portuguese regions.
Allergists and pediatricians were invited to participate, and one
to five physicians at each center joined the study. This study
comprised two visits, 3–6 wk apart, and was conducted
between July 2012 and February 2013.
Participants
All patients between 6 and 12 yr old, with a previous medical
diagnosis of asthma and allergic rhinitis, followed at the
participating centers, for at least three months, were eligible.
Children with other respiratory or chronic diseases that could
interfere with the study measurements, as well as parents and
children unable to fill the questionnaire, were excluded. The
study was approved by the Hospital CUF Descobertas’ ethics
committee, and each patient’s parents gave their written
informed consent.
Data Collection
Questionnaires were completed at each visit by children and
their caregivers, namely CARATKids, childhood Asthma
Control Test (cACT), and visual analog scale (VAS) of rhinitis
and asthma control. CARATKids’ initial version has 17
questions, with two answer options – ‘Yes’, scored as 1 = no
control (symptom/item present); and ‘No’, scored as
0 = control (symptom/item not present). The attending physi-
cian performed a medical evaluation and filled out VAS of
rhinitis and asthma control. Physicians were blinded to patient/
caregiver’s questionnaire responses. Characteristics of the
questionnaire according to patient-reported outcomes Ga2len
recommendations are presented on Table S1 (8).
Data Analysis
Sample size was established using COSMIN recommendations
(9). To assess over 100 participants, with an attrition rate of
10%, 115 patients were planned to be included. Sample
characteristics were described by standard descriptive statistics.
The variables’ distribution was plotted to visually assess the
distribution, and parametric and nonparametric tests were used
as appropriate.
The physicians’ VAS assessing asthma or rhinitis control
were categorized as dichotomous variables, classifying the
patient as controlled or uncontrolled. Disease control was
defined as a VAS measurement to be greater than six out of a
scale ranging from 0 (bad) to 10 (good), according to previous
reports (10). This was applied for the control of allergic rhinitis
as well as asthma control. Asthma control was also classified
according to the Global Initiative for Asthma (GINA) guide-
lines (5) and to cACT, with controlled asthma defined as a
score of 19 or less (11). A patient was considered controlled
when both asthma and rhinitis were controlled, taking into
account the GINA classification for asthma and physician
VAS classification for rhinitis. The rhinitis severity was
classified according to Allergic Rhinitis and its Impact on
Asthma (ARIA) recommendations (12). Patients who were
graded between 5.0 and 6.0 in the second visit’s control
variation VAS of both asthma and rhinitis were considered to
be clinically stable.
All answers were analyzed and response rates computed.
Results from physician assessment measures and children/
caregiver’s answers in each visit were pooled and plotted
against CARATKids scores and factors.
Item reduction
Item reduction was based on statistical criteria and on a
consensus meeting with an expert panel held in May 2013.
Stepwise logistic regression was performed to reduce the
17-item working questionnaire. Exploratory factor analysis
and internal consistency analysis were also performed and
taken into account for the item reduction. An item was
considered redundant, and it was discarded, if one of the
following occurred: a) responses over 95% in a single category
of a variable; b) a p-value of less than 0.10 in logistic regression
analysis; c) considerable cross-loading (>0.300 in more than
one factor) or low item-total correlation (<0.400) or increased
Cronbach’s alpha if the item was deleted.
Evaluation of CARATKids
Control of Allergic Rhinitis and Asthma Test for Children
measurement properties were assessed according to the
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COSMIN checklist (9): (i) reliability (internal consistency,
using Cronbach’s a; test–retest reliability, using intraclass
correlation coefficient (ICC)), (ii) responsiveness (within-
patient change in CARATKids score; Guyatt’s responsiveness
index (GRI)), (iii) discriminative properties and validity – (iii.a)
concurrent validity (physician assessment, self-assessment, and
cACT); (iii.b) longitudinal validity (physician assessment, self-
assessment, and cACT); and (iii.c) hypothesis testing, with a
priori predictions for concurrent validity for the correlation
defined as: (i) 0.5–0.7 with cACT; (ii) 0.4–0.7 with the
symptoms VAS; (iii) 0.4–0.6 with the physician’s assessment).
Confidence intervals (CI) for correlation coefficients were
calculated using bootstrap methods. Lower and upper limits of
the 95%CI corresponded to the percentiles 2.5 and 97.5 of the
distribution of the sample statistics after thousand replicates
(random samples with replacement of the same size as the
original sample) for each estimate.
The statistical analysis was carried out using SPPS 21.0.
(SPSS Inc., Chicago, IL, USA). The level of significance was
set at p < 0.05.
Results
The 113 patients included were assessed by 23 physicians at 11
outpatients’ clinics. Twelve patients (10.6%) did not attend the
second visit. The general characteristics of patients are sum-
marized in Table 1. Of the 103 with complete data on allergy,
98 were positive to house dust mites and 32 for pollens, mostly
grass pollen, and 13 sensitized to cat or dog.
Overall, 0.3% of all CARATKids questions were not
answered. The items with more missing items each with two
missings (1.8%) were ‘Wheezing’, by both children and
parents, ‘Rhinorrhoea’ and ‘Throat symptoms’ by children,
and ‘Nasal Obstruction’ and ‘Dyspnoea’ by parents.
For longitudinal analysis, full data on disease control were
available for 80 patients. Twenty-nine patients (36%) were
classified as having clinically stable asthma and rhinitis. The
unstable group included 51 patients, 15 with both unstable
asthma and rhinitis, 16 with only unstable rhinitis, and 20 with
only unstable asthma.
Item reduction
Internal consistency was better when questions were answered
by the parents and children separately than when answered
together. Moreover, the responses of parents and children
separately had better correlation coefficients with comparative
measures than questions answered by parents and children
together (data not shown). The expert panel, held to discuss
item selection, decided the questions should be answered by
the children and the parents separately (Fig. S1). The item
‘Hospitalization’ was eliminated, because it had more than
95% of answers ‘No’. Then, using stepwise logistic regression,
the items ‘Nasal pruritus’, ‘Throat symptoms’, and ‘Ocular
symptoms’ were excluded (Fig. S1). Internal consistency
analysis was in agreement with this 13-item version of the
questionnaire. Exploratory factor analysis identified four
factors and had no contribution to the item reduction. The
final questionnaire had 13 questions. Based on the data from
internal consistency and logistic regression analysis and the
associations with external comparison measures, eight ques-
tions are best answered by the children and five by the
parents.
Properties and Evaluation of CARATKids
Control of Allergic Rhinitis and Asthma Test for Children had
a median (P25-P75) score of 4 (2–7) in the first visit and of 3
(1–5) in the second one. Nine patients (8.2%) in visit 1 and 13
(15.6%) in visit 2 had the minimum score of 0, and 2 (1.8%) in
visit 1 and 1 (0.9%) in visit 2 had the maximum score of 13.
The mean (s.d.) score difference between the two visits was of
1.46 (3.34), p < 0.001. Control of Allergic Rhinitis and
Asthma Test for Children scores were significantly different
when comparing patients with controlled, uncontrolled, and
partly controlled asthma, and when comparing children with
mild rhinitis with those with moderate to severe disease
(p < 0.05). Scores differed significantly between physician’s
treatment decision groups (reduction, maintenance, or
increase), GINA classification of asthma control, and ARIA
classification of severity (Fig. 1 and Table S2). In both visits,
significant differences are observed in CARATKids scores
between control groups defined by cACT (Fig. 1).
In the internal consistency analysis, the Cronbach’s alpha
was 0.80 for CARATKids.
Table 1 Characteristics of participants
Visit 1
n = 113
Visit 2
n = 101
Age mean (s.d.) yr 8.75 (1.86) 8.84 (1.82)
Gender n (%)
Male 69 (61.1) 64 (63.4)
Female 44 (38.9) 37 (36.6)
cACT score (p25–p75) 23 (19–25) 24 (21.3–26)
Physician assessment
Asthma Control – GINA n (%)
Uncontrolled 12 (10.6) 4 (3.5)
Partly controlled 36 (31.9) 18 (15.9)
Controlled 46 (40.7) 65 (57.5)
Rhinitis – ARIA n (%)
Intermittent 43 (38.1) 50 (44.2)
Persistent 66 (58.4) 49 (43.4)
Mild 73 (64.6) 82 (72.6)
Moderate/Severe 37 (32.7) 19 (16.8)
VAS control median (p25–p75)
Asthma 5 (8–9) 9 (8–9.5)
Rhinitis 6 (4–8) 8 (6–9)
Treatment decision n (%)
Reduce 8 (7.1) 9 (9.1)
Maintain 51 (45.5) 68 (68.7)
Increase 53 (47.3) 22 (22.2)
cACT, childhood Asthma Control Test; GINA, Global Initiative for
Asthma; ARIA, Allergic Rhinitis and its Impact on Asthma; VAS, visual
analog scale.
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All correlation coefficients met the a priori predictions
(Table 2). Coefficients varied between 0.430 and 0.689 (all
p < 0.001). Correlation coefficient of CARATKids scores with
GINA classification of asthma control was of 0.60 (95%CI
0.728; 0.442) and of 0.430 (0.235; 0.584) with ARIA
classification of rhinitis severity (p < 0.001).
Receiver operating characteristic curves for CARATKids
are shown in Fig. 2. The areas under the curve for CARATKids
ranged from 0.761 (physician evaluation of rhinitis control) to
0.826 (cACT).
In the test–retest reliability analysis, the ICC was 0.80 in the
stable group. When evaluating responsiveness, we observed a
significant within-patient change of CARATKids score in
clinically unstable patients, not only when both the conditions
were unstable (mean (s.d.) change of 3.8 (2.83), p < 0.001)
but also when at least one was unstable (2.1 (3.54),
p < 0.001). In the stable group, there was a non-significant
difference (mean (s.d.) of 0.59 (2.52), p = 0.23) between
CARATKids scores in the two visits. The GRI was of 1.51 in
the group with both conditions unstable.
The range of the correlation coefficients between the
variation in CARATKids scores and the variation in physician
assessment of control using VAS was 0.454 and 0.446,
meeting the a priori prediction (Table 2).
Discussion
This article describes the clinical evaluation of CARATKids,
the first questionnaire developed to concurrently assess asthma
and allergic rhinitis control in 6- to 12-yr-old children. A
process of item reduction from the initial 17-item version of
CARATKids was performed to reduce redundancy and
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Figure 1 Mean and 95% confidence intervals of CARATKids scores in both visits 1 and 2 with: (a) physician’s decision of treatment reduction,
maintenance, or increase; (b) asthma control classified by cACT; (c) GINA classification of asthma control; and (d) ARIA classification of rhinitis
severity. CARATKids, Control of Allergic Rhinitis and Asthma Test for Children; cACT, childhood Asthma Control Test; ARIA, Allergic Rhinitis and
its Impact on Asthma; GINA, Global Initiative for Asthma.
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improve the questionnaire’s reliability and validity. The
13-item questionnaire showed to have good discriminative
properties.
Of the 13 items, five are to be answered by parents and eight
by children (Fig. S1). Although this method of a twofold
answer was found to be the most adequate solution, the
usability of the questionnaire is somehow reduced by the
parent and child response method. However, previous studies
on asthma also observed divergence between children and
parent-reported variables, with some sets of questions being
better answered by each of them (11, 13, 14). In fact, cACT
also has a twofold answer method (11). The questions on
sneezing and other nasal symptoms had better results when
answered by the children, while parents may be less aware of
the frequency of these symptoms. In the cognitive interviews
performed in the initial stages of CARATKids development,
this lack of concordance was already observed (7).
The internal consistency was satisfactory (15), being similar
or better than other questionnaires evaluating asthma control
in children, such as cACT (11), Asthma Control Questionnaire
(ACQ) in Children (CAN) (16), Test for Respiratory and
Asthma Control in Kids (TRACK) (17), ACQ in children (18),
or Asthma Quiz (19) (Table 3); however, it was slightly lower
than the one in adult’s questionnaires, as CARAT (20) and
Asthma Control Test (ACT) (21) (Table 3). The areas under
the curve were high (0.761–0.826), namely when compared with
physician assessment of control and cACT (Fig. 2) assumed as
comparators. These are in the same range of those previously
observed in studies on adults and are higher than the ones
reported for cACT (Table 3).
A gold standard for ARA control has not been established
yet. Therefore, concurrent validity was assessed using different
external measures of control, based on physicians, children, and
caregivers’ assessments. A priori predictions were met, and all
coefficients are in the same range as those observed with other
tools to assess control, both in children and adults (Table 3).
In test–retest reliability analysis, CARATKids scores
showed an ICC similar or better than those of ACQ in
children, TRACK, CAN, ACT, and CARAT (Table 3).
Large responsiveness, greater than 0.8 was observed (22).
Moreover, the magnitude of GRI of CARATKids (1.51) was
similar to the one of CARAT (1.54).
Regarding longitudinal validity, correlation coefficients
were higher than a priori predictions for physician and
children VAS of both asthma and rhinitis control (Table 2),
but not for cACT. As we could not find longitudinal validity
assessment of cACT, it is difficult to interpret the low
correlation coefficient we observed between DCARATKids
scores and DcACT. This low correlation may be related to
differences in sensitivities or responsiveness of the question-
naires. In any case, in both visits, significant differences were
observed in CARATKids scores between cACT control
groups (Fig. 1). The only control questionnaires for children
with published longitudinal validity results are ACQ in
Table 2 Correlation coefficients between CARATKids with external measures of control and of between-visits changes (variation) of
CARATKids scores (DCARATKids) and between-visits changes of external measures of control
Physician Assessment – VAS/DVAS Children Assessment – VAS/DVAS
cACT/DcACTAsthma Control Rhinitis Control Asthma Control Rhinitis Control
CARATKids 0.548 (0.678; 0.371) 0.499 (0.648; 0.308) 0.608 (0.439;0.74) 0.446 (0.266;0.591) 0.689 (0.805; 0.543)
DCARATKids 0.446 (0.656; 0.163) 0.454 (0.687; 0.177) 0.466 (0.19;0.687) 0.447 (0.172;0.663) 0.344 (0.633; 0.033)
Data are presented as Spearmen correlation coefficients (95%CI). CARATKids, Control of Allergic Rhinitis and Asthma Test for Children; VAS,
visual analog scale; cACT, childhood Asthma Control Test.
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Figure 2 Receiver operating characteristic curves of CARAT10 score against (a) asthma control classified by cACT; physician assessment of (b)
rhinitis and (c) asthma control. ROC, receiver operating characteristic; cACT, childhood Asthma Control Test; VAS, visual analog scale; AUC, area
under curve.
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children and CAN. The CARATKids longitudinal results are
similar to CAN and worse than ACQ in children (Table 3).
This may be related to differences in the study design, as ACQ
for children was evaluated in a single center, with 3 visits in 4
wk (0, 1, and 4 wk) that included only 35 children (18).
Moreover, a guideline-based assessment of asthma control is
already available, while the control of rhinitis was defined by
physician-derived measures because no gold standard measure
is available yet. It is known that there is a bias associated with
the physician assessment of control (23), which can partly
explain the somewhat lower CARATKids scores. Neverthe-
less, CARATKids longitudinal validity results were similar to
those of control questionnaires in adults and of the CAN
questionnaire (Table 3).
This study has several limitations. Interobserver agreement
may have been reduced by the high number of observes
included, as data were collected by 23 physicians at 11
outpatients’ clinics. Nevertheless, this dispersion of data
collection may improve the generalizability to the real-world
clinical practice. Also, patients were not equally distributed
across the range of asthma and rhinitis severity, and for some
subgroups, the number of patients was low. This was specially
relevant for uncontrolled asthma subgroup for which only 12
patients were accessed. Furthermore, CARATKids was only
assessed in children established asthma and allergic rhinitis
diagnosis; therefore, its performance in children with only one
of the diseases remains unknown.
Minimal important difference and cutoff values are
important properties that were not objectives of this study
and should be defined in future studies. This would be
specially important to use CARATKids in intervention
studies. Nevertheless, we conducted exploratory analysis of
the cutoff values. We considered one point for each ‘Yes’
answer and classified the CARATKids scores as controlled
(<4), insufficiently controlled (4, 5), and uncontrolled (>5).
Uncontrolled asthma or rhinitis can be ruled out with a
score of three or less and ruled in with a score higher than
five with good sensitivity and specificity (Table S3). The
clinical usefulness of routine assessment of control in
children, using questionnaires, also needs to be assessed in
long-term studies.
In conclusion, CARATKids, the first questionnaire assess-
ing allergic rhinitis and asthma control for children 6–12 yr
old, showed adequate psychometric properties to be used in
clinical practice.
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Table 3 Psychometric properties of control questionnaires for asthma only, and for asthma and allergic rhinitis
Internal
consistency
Concurrent
validity
ROC curves
(AUC)
Test–retest
ICC Responsiveness Longitudinal validity
For children
CARATKids 0.80 0.37–0.73, all
p < 0.001
0.76–0.83 0.80 Significant within-patient
change
0.32–0.44, all
p < 0.05
cACT (11) 0.79 0.47–0.68, all
p < 0.001
0.67–0.71 NA NA NA
ACQ in children (18, 24) 0.75 0.52–0.83 0.60 0.79 Significant within-patient
change
0.66–0.89
TRACK (17, 25) 0.75 NA 0.78 0.63 Significant within-patient
change
NA
Asthma Quiz (19) 0.73 NA NA NA NA NA
CAN (16) 0.82 0.18; 0.14* 0.73–0.77 0.73 Significant within-patient
change
0.34; 0.23*
For adults
CARAT (20, 26) 0.85 0.48–0.71, all
p < 0.001
0.82 0.82 Significant within-patient
change
0.31–0.65
ACT (21, 27) 0.85 0.31–0.89, all
p < 0.001
0.69 0.77 Significant within-patient
change
0.29–0.81, all
p < 0.001
ACQ (27, 28) NA 0.19–0.76 0.85–0.90 0.90 Significant within-patient
change
0.15–0.73
When available, data from different sources were used and the higher values on each questionnaire description are presented. CARATKids,
Control of Allergic Rhinitis and Asthma Test for Children; cACT, childhood Asthma Control Test; ACQ, Asthma Control Questionnaire; TRACK,
Test for Respiratory and Asthma Control in Kids; CAN, Asthma Control Questionnaire for Children; CARAT, Control of Allergic Rhinitis and
Asthma Test; ACT, Asthma Control Test; NA, not available.
*Values are for patient and carer’s versions, respectively.
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Additional Supporting Information may be found in the online
version of this article:
Table S1. Questionnaire characteristics according to patient-
reported outcomes’ recommendations of Ga2len (8).
Table S2. CARATKids scores in visit 1 and visit 2 by
gender, by GINA and ARIA classifications, and by physician
treatment decision.
Table S3. Sensitivity and Specificity for CARATKids’ 3 and
5 cutoff values.
Figure S1. CARATKids initial 17 items and final 13-item.
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